NEJM This Week — January 27, 2022
Featuring articles on remdesivir for prevention of Covid-19 progression, cardiovascular and cancer risk with tofacitinib, tricuspid repair in mitral-valve surgery, duration of Covid-19 vaccine protection in the U.K., polatuzumab vedotin in diffuse large B-cell lymphoma, and anti-idiotype antibodies in SARS-CoV-2; a review article on medical conditions and high-altitude travel; a case report of a boy with fever, joint pain, and abdominal cramping; and Perspective articles on universal coronavirus vaccines, on transparency and the doctor–patient relationship, and on “Please don’t keep me”.
